These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18797198)

  • 41. Benign intracranial hypertension in association with acute lymphoblastic leukemia.
    Sastry J; Karandikar SS; English MW
    Pediatr Hematol Oncol; 2003 Mar; 20(2):157-60. PubMed ID: 12554527
    [No Abstract]   [Full Text] [Related]  

  • 42. Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
    González Pérez P; Serrano-Pozo A; Franco-Macías E; Montes-Latorre E; Gómez-Aranda F; Campos T
    Eur J Neurol; 2007 Jul; 14(7):826-8. PubMed ID: 17594344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of acute lymphocytic leukemia in adult].
    Takahashi I; Inagaki N; Nakada H; Nishimura M; Hayashi N; Sekito N; Nonaka K; Takeuchi M; Osada K; Matuzaki T
    Rinsho Ketsueki; 1989 Aug; 30(8):1167-70. PubMed ID: 2601026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased factor VIII activity and dural sinus thrombosis.
    Celkan T; Ozkan A; Apak H; Kuruoglu S; Yuksel L; Yildiz I
    Med Pediatr Oncol; 2002 Jul; 39(1):71-2. PubMed ID: 12116089
    [No Abstract]   [Full Text] [Related]  

  • 45. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.
    Steiner I; Aebi C; Ridolfi Lüthy A; Wagner B; Leibundgut K
    Pediatr Blood Cancer; 2008 Mar; 50(3):647-9. PubMed ID: 17278117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
    Olek MJ; Bordeaux B; Leshner RT
    J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
    Berenguer-Potenciano M; Villora-Morcillo N; Nunez-Enamorado N; Perez-Alonso V; Camacho-Salas A; Simon-De Las Heras R
    Rev Neurol; 2015 Jan; 60(2):91-2. PubMed ID: 25583593
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy.
    Hildebrandt G; Holler E; Woenkhaus M; Quarch G; Reichle A; Schalke B; Andreesen R
    Ann Oncol; 2000 Jun; 11(6):743-7. PubMed ID: 10942065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
    Yasu T; Ohno N; Kawamata T; Kurokawa Y
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome.
    Hogan-Dann CM; Fellmeth WG; McGuire SA; Kiley VA
    JAMA; 1984 Nov 23-30; 252(20):2862-3. PubMed ID: 6092732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
    Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of the treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in 1991-2000].
    Miakova NV; Hartmann R; Rudneva AE; Trubina NM; Fechina LG; Timakov AM; Shamardina AV; Lebedev VV; Varfolomeeva SR; Dudkin SD; Dyshlevaia ZM; Timofeeva VN; Rumiantsev AG; Henze H; Karachunskiĭ AI
    Vopr Onkol; 2002; 48(3):340-6. PubMed ID: 12455359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia.
    Silverman JA; Reynolds L; Deitcher SR
    J Clin Pharmacol; 2013 Nov; 53(11):1139-45. PubMed ID: 23907766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia].
    Fujieda H; Hojo H; Ohyashiki JH; Ohyashiki K; Toyama K; Baba Y
    Rinsho Ketsueki; 1989 Jul; 30(7):1037-41. PubMed ID: 2681881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).
    Igarashi M; Thompson EI; Rivera GK
    Med Pediatr Oncol; 1995 Aug; 25(2):113-6. PubMed ID: 7603395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute lymphoblastic leukemia in Ehlers-Danlos syndrome.
    Asano T; Yamamoto M
    Int J Hematol; 1996 Oct; 64(3-4):283-5. PubMed ID: 8923793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
    Jain S; Kapoor G
    Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
    [No Abstract]   [Full Text] [Related]  

  • 59. Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.
    Turner SR; Pinsk M
    J Pediatr Hematol Oncol; 2008 Jan; 30(1):58-60. PubMed ID: 18176182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation.
    Nakamura T; Hashiguchi A; Suzuki S; Uozumi K; Tokunaga S; Takashima H
    Neurogenetics; 2012 Feb; 13(1):77-82. PubMed ID: 22271166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.